To provide initial evidence for this claim in PD patients, the expression levels of SNCA‐AS1 and SNCA were analyzed in PBMCs of PD‐affected patients vs. control (n = 16) (Figure 5e). The gene discussed is SNCA; the disease is Parkinson disease.